Status:

COMPLETED

A Study to Compare Dysport® and Botox® in the Treatment of Cervical Dystonia

Lead Sponsor:

Seoul National University Hospital

Collaborating Sponsors:

Ipsen

Medical Research Collaborating Center, Seoul, Korea

Conditions:

Cervical Dystonia

Eligibility:

All Genders

20-80 years

Phase:

PHASE4

Brief Summary

1. to examine the non-inferiority of Dysport in the clinical efficacy and safety in comparison with Botox®, assuming a bioequivalence ratio of 2.5:1 units, in the treatment of Cervical dystonia. 2. do...

Detailed Description

1. Prospective, randomized, head-to-head, double-blind, cross-over study. 2. Total patients: A group 51, B group 51 3. Study duration: 16 + 4 + 16 weeks. Eligible patients will be randomised at baseli...

Eligibility Criteria

Inclusion

  • Patients ≥ 18 years of age of both genders,
  • Cervical dystonia
  • symptoms with a minimum duration of 18 months,
  • Negative pregnancy test in sexually active women,
  • Able to participate in the study (understand goals of botulinum toxin A treatment and sign Informed Consent Form).

Exclusion

  • Patient with cervical contractures
  • Known significant underlying dysphasia
  • Patients who have received botulinum toxin treatment within the past 4 months.
  • Contraindication to botulinum toxin treatment
  • Any disease that might affect neuromuscular function (Myasthenia Gravis, Eaton-Lambert syndrome, ALS …)
  • Patients who have received oral anti-spasticity medication, phenol therapy, myotomy or denervation surgery, deep brain stimulation for cervical dystonia,
  • Patients who required more than 500 units of Dysport or 200 units of Botox.
  • Any concomitant treatment that could interfere with the action of botulinum toxin,
  • Subjects having participated within the last 3 months or currently participating in an investigational drug study,
  • Pregnancy,
  • Lactation.

Key Trial Info

Start Date :

August 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2011

Estimated Enrollment :

103 Patients enrolled

Trial Details

Trial ID

NCT00950664

Start Date

August 1 2009

End Date

July 1 2011

Last Update

July 5 2017

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Bundang Seoul Natiuonal University Hospital

Seongnam-si, Gyeonggi-do, South Korea, 463-070

2

Dong-A University Hospital

Busan, South Korea, 602-715

3

Hanyang University Hospital

Seoul, South Korea, 133-792

4

Samsung Medical Center

Seoul, South Korea, 135-710